Tocqueville Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-18,837
| Closed | -$366K | – | 872 |
|
|
2018
Q1 | $366K | Sell |
18,837
-315
| -2% | -$6.18K | ﹤0.01% | 668 |
|
|
2017
Q4 | $319K | Hold |
19,152
| – | – | ﹤0.01% | 692 |
|
|
2017
Q3 | $389K | Hold |
19,152
| – | – | ﹤0.01% | 664 |
|
|
2017
Q2 | $308K | Hold |
19,152
| – | – | ﹤0.01% | 666 |
|
|
2017
Q1 | $242K | Hold |
19,152
| – | – | ﹤0.01% | 707 |
|
|
2016
Q4 | $254K | Sell |
19,152
-25,000
| -57% | -$427K | ﹤0.01% | 712 |
|
|
2016
Q3 | $1.05M | Buy |
44,152
+2,909
| +7% | +$78.2K | 0.01% | 497 |
|
|
2016
Q2 | $1.19M | Hold |
41,243
| – | – | 0.01% | 485 |
|
|
2016
Q1 | $1.32M | Buy |
41,243
+4,676
| +13% | +$164K | 0.02% | 455 |
|
|
2015
Q4 | $1.56M | Buy |
36,567
+5,846
| +19% | +$234K | 0.02% | 457 |
|
|
2015
Q3 | $1.08M | Hold |
30,721
| – | – | 0.01% | 549 |
|
|
2015
Q2 | $1.41M | Hold |
30,721
| – | – | 0.02% | 511 |
|
|
2015
Q1 | $1.44M | Hold |
30,721
| – | – | 0.02% | 525 |
|
|
2014
Q4 | $973K | Buy |
30,721
+10,721
| +54% | +$314K | 0.01% | 586 |
|
|
2014
Q3 | $474K | Hold |
20,000
| – | – | 0.01% | 632 |
|
|
2014
Q2 | $600K | Buy |
20,000
+4,000
| +25% | +$108K | 0.01% | 676 |
|
|
2014
Q1 | $423K | Buy |
+16,000
| New | +$400K | 0.01% | 613 |
|
Tocqueville Asset Management's IPXL Position: Q2 2018 in Review
Tocqueville Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 18,837 shares — an estimated $366K sold.
Tocqueville Asset Management first reported a position in IPXL in Q1 2014 and held it in 17 quarters. The position peaked at $1.56M in Q4 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Tocqueville Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Tocqueville Asset Management sold 18,837 Impax Laboratories, Inc. shares in Q2 2018, an estimated $366K.
- Tocqueville Asset Management first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 17 quarters.
- Tocqueville Asset Management's Impax Laboratories, Inc. position peaked at $1.56M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Tocqueville Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.